DR Reddys Laboratories Limited Naproxen Export Data — India (DGFT 2022–2026)

Name: DR Reddys Laboratories Limited Naproxen Export Records India — #12 Exporter, 18 Shipments, $900.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Naproxen

India Pharmaceutical Trade Intelligence

$133.8M192 Suppliers76 CountriesHS 30049069

ExportsIndia → UNITED STATES42.1%India → CANADA21.1%

ImportsUNITED STATES → India$391.7K GERMANY → India$185.0K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

DR Reddys Laboratories Limited — Naproxen Exporter #12 | $900.0K Trade Value | TransData Nexus | TransData Nexus

DR Reddys Laboratories Limited — Naproxen Exporter Profile

Indian Pharmaceutical Exporter · #12 for Naproxen · $900.0K export value · DGFT Verified

DR Reddys Laboratories Limited is the #12 Indian exporter of Naproxen with $900.0K in export value and 18 verified shipments. DR Reddys Laboratories Limited holds a 0.7% market share in Naproxen exports across 1 countries. The company exports 37 pharmaceutical products worth $62.4M across 17 therapeutic categories.

DR Reddys Laboratories Limited — Naproxen Export Profile: Buyers & Destinations

DR Reddys Laboratories Limited Naproxen export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Naproxen?

Country	Value	Shipments	Share
UNITED STATES	$46.1M	923	50.5%
SLOVENIA	$13.8M	276	15.1%
MALTA	$8.6M	528	9.5%
CANADA	$6.5M	129	7.1%

Who Are the Top Buyers of Naproxen from India?

Buyer	Country	Value	Orders
GLENMARK PHARMACEUTICALS INC., USA	UNITED STATES	$11.0M	231
KRKA D.D., NOVO MESTO	SLOVENIA	$6.3M	126
APL SWIFT SERVICES (MALTA) LTD.,	MALTA	$5.2M	291
ATNAHS PHARMA UK LIMITED	SPAIN	$5.1M	156
AMNEAL PHARMACEUTICALS, LLC (KY)	UNITED STATES	$4.1M	82
TIME-CAP LABS,	UNITED STATES	$3.6M	90
KRKA D D NOVO MESTO	SLOVENIA	$2.8M	56
KRKA, D.D., NOVO MESTO	SLOVENIA	$2.7M	54
DR REDDYS LABORATORIES INC	UNITED STATES	$1.1M	23
MYLAN PHARMACEUTICALS ULC,	CANADA	$350.0K	7

India's Naproxen is purchased by 366 buyers worldwide. The top buyer is GLENMARK PHARMACEUTICALS INC., USA (UNITED STATES), followed by KRKA D.D., NOVO MESTO and APL SWIFT SERVICES (MALTA) LTD.,.

How Does DR Reddys Laboratories Limited Compare to Nearest Naproxen Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
14	MEDREICH LIMITED	$1.9M	101	4	$18.8K
15	S KANT HEALTHCARE LIMITED	$1.6M	36	1	$45.7K
12	DR REDDYS LABORATORIES LIMITED ★	$900.0K	18	1	$50.0K

DR Reddys Laboratories Limited ranks #12 among 192 Indian Naproxen exporters. Average shipment value of $50.0K compared to the market average of $405.2K. The closest competitors by value are MEDREICH LIMITED and S KANT HEALTHCARE LIMITED.

Which Indian Ports Ship Naproxen Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	429	12.6%
SAHAR AIR CARGO ACC (INBOM4)	245	7.2%
SAHAR AIR	236	6.9%
DELHI AIR CARGO ACC (INDEL4)	211	6.2%
JNPT/ NHAVA SHEVA SEA	156	4.6%
HYDERABAD ICD	145	4.2%
VIZAG SEA	140	4.1%
BANGALORE AIR	128	3.7%

Geopolitical & Trade Policy Impact on DR Reddys Laboratories Limited's Naproxen Exports

The global pharmaceutical export landscape has been significantly influenced by recent geopolitical events. The 2026 Strait of Hormuz crisis, initiated by military conflicts involving the United States, Israel, and Iran, led to the effective halt of shipping traffic through this critical maritime route, disrupting approximately 20% of the world's daily oil supply and causing a surge in global energy prices. (en.wikipedia.org) This disruption has had a cascading effect on shipping costs and insurance premiums, directly impacting Indian pharmaceutical exporters like Dr. Reddy's, which rely on these routes for timely delivery of products to key markets.

Simultaneously, the 2025–26 United States–India diplomatic and trade crisis, marked by the imposition of a 50% tariff on Indian exports by the U.S., has posed additional challenges. These tariffs have increased the cost of Indian pharmaceutical products in the U.S. market, potentially affecting the competitiveness of companies like Dr. Reddy's. (en.wikipedia.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement for exporters. Dr. Reddy's has been proactive in adhering to these regulations, ensuring that its products meet the stringent safety and traceability standards mandated by the EU, thereby maintaining its market access and reputation.

DR Reddys Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Dr. Reddy's has demonstrated a commitment to quality by securing approvals from major regulatory bodies, including the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Medicines Agency (EMA). The company's recent Biologics License Application (BLA) submission for a proposed interchangeable biosimilar to Orencia® (abatacept) underscores its adherence to rigorous regulatory processes. (stockwatch.com)

However, the company has faced regulatory challenges, such as the tax audit decision from the Russian Federal Tax Service in January 2026, which reclassified certain marketing services as taxable, resulting in a penalty. (stocktitan.net) Such incidents highlight the complexities of operating in diverse regulatory environments and the importance of robust compliance frameworks.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Naproxen shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: DR Reddys Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 76+ countries, 366+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Naproxen

Naproxen

DR Reddys Laboratories Limited — Naproxen Exporter Profile

DR Reddys Laboratories Limited — Naproxen Export Profile: Buyers & Destinations

Where Does India Export Naproxen?

Who Are the Top Buyers of Naproxen from India?

What Is India's Total Naproxen Export Value and How Much Does DR Reddys Laboratories Limited Contribute?

What Is the Average Shipment Value for DR Reddys Laboratories Limited's Naproxen Exports?

How Does DR Reddys Laboratories Limited Compare to Other Indian Naproxen Exporters?

Regulatory Requirements: Exporting Naproxen to Key Markets

United States — FDA

Canada — HC

How Does DR Reddys Laboratories Limited Compare to Nearest Naproxen Exporters?

Which Indian Ports Ship Naproxen Exports?

What Other Analgesics & Antipyretics Products Does DR Reddys Laboratories Limited Export?

Geopolitical & Trade Policy Impact on DR Reddys Laboratories Limited's Naproxen Exports

DR Reddys Laboratories Limited — Regulatory Compliance & Quality Standards

About DR Reddys Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Naproxen Export Data from DR Reddys Laboratories Limited

Naproxen Stats

Company Overview

Top Products by DR Reddys Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source